William Fry LLP has long been a force in corporate transactions, including private and public M&A. In recent times, it has advised on a number of the largest M&A and private equity deals in the market, including Amgen’s headline acquisition of Horizon Therapeutics. The firm has a history of transactions in the healthcare and life sciences, TMT, energy and renewables, financial services and insurance, and real estate sectors. It has also advised on a series of transactions in the data centre sector. Department head Stephen Keogh and public takeovers leader Myra Garrett are top practitioners, along with energy transactions expert Máire O’Neill and technology and life sciences specialist Andrew McIntyre . Mark Talbot is rated for public M&A, while Brian Butterwick has extensive international connections and Mark Quealy brings further expertise in life sciences, private equity and venture capital.
Legal 500 redaktioneller Kommentar
- Profil
- Soziale Medien
Kernmandanten
- Echelon Data Centres
- Amgen Inc
- Uniphar
- JOLT
- Department of Finance
- DCC
- Tines
- Irish Rugby Football Union
- UKG Group
- J&E Davy
Highlight-Mandate
- Advised Amgen on its acquisition of Horizon Therapeutics.
- Advised the Department of Finance on the directed buyback by AIB Group from the Minister for Finance.
- Advised Echelon Data Centres on the strategic investment in the company by Starwood Capital Group.
Anwält*innen
Führende Partner*innen
Die stärksten Partner*innen ihres Praxisbereichs, die eine führende Rolle in signifikanten Mandaten einnehmen und weitreichende Anerkennung unter Wettbewerbern und Mandanten genießen.
Partner*innen der nächsten Generation
Juniorpartner*innen, die im Markt von Mandanten und Wettbewerbern anerkannt werden und in einigen Mandaten eine Schlüsselrolle einnehmen.
Praxisleitung
Stephen Keogh
Weitere Kernanwält*innen
Myra Garrett; Andrew McIntyre; Mark Quealy; Mark Talbot; Máire O’Neill; Bryan Bourke; Ronan Shanahan; Fiachra Cork; Carol Eager, Gavin White